The CatB proteolytic responses support early and prolonged signaling events that work to maintain proteostasis and reduce pathogenic protein deposition and, when effective, they perhaps explain the extended nature of AD in many individuals. This evidence concerns the gene TYRP1 and Alzheimer disease.